LMR Partners’s Guardant Health GH Stock Holding History

LMR Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Buy	+16,074	New	+$1.75M	0.01%	847
2026 Q1	–	Sell	-16,800	Closed	-$1.72M	–	1623
2025 Q4	$1.72M	Buy	16,800 +10,000	+147%	+$895K	﹤0.01%	850
2025 Q3	$425K	Buy	+6,800	New	+$370K	﹤0.01%	1113
2025 Q2	–	Sell	-11,524	Closed	-$491K	–	1480
2025 Q1	$491K	Buy	+11,524	New	+$497K	﹤0.01%	920
2024 Q4	–	Sell	-10,000	Closed	-$229K	–	1356
2024 Q3	$229K	Buy	+10,000	New	+$283K	﹤0.01%	967
2022 Q4	–	Sell	-38,011	Closed	-$2.05M	–	1176
2022 Q3	$2.05M	Sell	38,011 -122,633	-76%	-$6.3M	0.04%	510
2022 Q2	$6.48M	Buy	160,644 +137,702	+600%	+$6.82M	0.11%	232
2022 Q1	$1.52M	Sell	22,942 -124,605	-84%	-$8.53M	0.02%	646
2021 Q4	$14.8M	Buy	147,547 +98,826	+203%	+$10.2M	0.15%	124
2021 Q3	$6.09M	Buy	+48,721	New	+$5.79M	0.07%	225
2021 Q2	–	Sell	-35,153	Closed	-$5.37M	–	1206
2021 Q1	$5.37M	Buy	+35,153	New	+$5.31M	0.13%	148

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

LMR Partners's GH Position: Q2 2026 in Review

LMR Partners opened a new position in Guardant Health (GH) in Q2 2026: 16,074 shares worth $2.41M. The stake represents 0.01% of the portfolio and ranks #847 among its holdings. This is a return to the name: LMR Partners previously reported a position in GH as recently as Q4 2025.

LMR Partners first reported a position in GH in Q1 2021 and has held it in 11 quarters since. The position peaked at $14.8M in Q4 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

LMR Partners held 16,074 shares of Guardant Health worth $2.41M as of Q2 2026.
Guardant Health was a new LMR Partners position in Q2 2026.
Guardant Health made up 0.01% of LMR Partners's portfolio in Q2 2026, its #847 holding.
LMR Partners first reported a position in Guardant Health in Q1 2021 and has held it in 11 quarters since.
LMR Partners's Guardant Health position peaked at $14.8M in Q4 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.